It's been a decade and IsoPet is sold below cost, not even close to break even, and that's with bogus accounting that ignores RDGL overhead. All increased IsoPet sales do is accelerate the cash burn. There's just no plausible path to profitability. IsoPet is a hopeless distraction.
Moreover, FDA made clear years ago that uncontrolled and unmonitored IsoPet anecdotes are useless for considering Radiogel for human trials. Again, IsoPet is a hopeless distraction.
That's the reality of RDGL. By all appearances, RDGL is a scam
Market Data 
Markets 
